WST - West Pharmaceutical Services, Inc.

NYSE - Nasdaq Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 26.83B
Enterprise value 26.25B
Trailing P/E 49.55
Forward P/E 46.30
PEG ratio (5-yr expected) 8.84
Price/sales (ttm)9.49
Price/book (mrq)9.66
Enterprise value/revenue 9.09
Enterprise value/EBITDA 32.48

Trading information

Stock price history

Beta (5Y monthly) 1.09
52-week change 39.00%
S&P500 52-week change 32.54%
52-week high 3376.72
52-week low 3206.19
50-day moving average 3352.67
200-day moving average 3287.65

Share statistics

Avg vol (3-month) 3436.16k
Avg vol (10-day) 3370.38k
Shares outstanding 574.24M
Implied shares outstanding 6N/A
Float 873.84M
% held by insiders 10.53%
% held by institutions 195.06%
Shares short (14 May 2023) 4863.76k
Short ratio (14 May 2023) 42
Short % of float (14 May 2023) 41.52%
Short % of shares outstanding (14 May 2023) 41.16%
Shares short (prior month 13 Apr 2023) 41.35M

Dividends & splits

Forward annual dividend rate 40.76
Forward annual dividend yield 40.22%
Trailing annual dividend rate 30.74
Trailing annual dividend yield 30.22%
5-year average dividend yield 40.32
Payout ratio 410.15%
Dividend date 301 Aug 2023
Ex-dividend date 424 Jul 2023
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 19.15%
Operating margin (ttm)25.74%

Management effectiveness

Return on assets (ttm)13.22%
Return on equity (ttm)21.64%

Income statement

Revenue (ttm)2.88B
Revenue per share (ttm)38.74
Quarterly revenue growth (yoy)-0.50%
Gross profit (ttm)1.14B
Net income avi to common (ttm)552.1M
Diluted EPS (ttm)7.28
Quarterly earnings growth (yoy)-19.40%

Balance sheet

Total cash (mrq)886.3M
Total cash per share (mrq)11.94
Total debt (mrq)314.4M
Total debt/equity (mrq)11.32
Current ratio (mrq)3.62
Book value per share (mrq)37.42

Cash flow statement

Operating cash flow (ttm)710.9M
Levered free cash flow (ttm)264.94M